D Elder

1.2k total citations
11 papers, 578 citations indexed

About

D Elder is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Dermatology. According to data from OpenAlex, D Elder has authored 11 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Dermatology. Recurrent topics in D Elder's work include Cutaneous Melanoma Detection and Management (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (2 papers). D Elder is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (2 papers). D Elder collaborates with scholars based in United States. D Elder's co-authors include Meenhard Herlyn, K. Montone, Patricia Van Belle, Rosalie Elenitsas, Nadia Marano, B.F.D. Ghrist, Barbara Atkinson, Alonzo H. Ross, Mark Bothwell and Carolyn S. Ernst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

D Elder

11 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Elder United States	7	238	210	175	121	78	11	578
Susan J. Hines United States	7	302 1.3×	257 1.2×	103 0.6×	83 0.7×	21 0.3×	8	674
P Rossino Italy	11	318 1.3×	80 0.4×	96 0.5×	117 1.0×	229 2.9×	16	724
Jacqueline Perreau France	7	337 1.4×	233 1.1×	186 1.1×	265 2.2×	108 1.4×	11	762
Michael Stefanidakis Finland	11	270 1.1×	132 0.6×	83 0.5×	226 1.9×	70 0.9×	13	726
Marta Koch Belgium	7	562 2.4×	292 1.4×	105 0.6×	123 1.0×	86 1.1×	7	848
Annick Francis Belgium	11	496 2.1×	109 0.5×	80 0.5×	49 0.4×	106 1.4×	16	800
Thomas Crowell United States	7	416 1.7×	69 0.3×	480 2.7×	114 0.9×	60 0.8×	10	975
Diego Luis-Ravelo Spain	14	338 1.4×	216 1.0×	64 0.4×	50 0.4×	42 0.5×	20	663
Huibin Yang United States	16	622 2.6×	316 1.5×	141 0.8×	233 1.9×	85 1.1×	22	1.0k
Ryan C. Winger United States	12	279 1.2×	145 0.7×	60 0.3×	450 3.7×	30 0.4×	25	946

Countries citing papers authored by D Elder

Since Specialization

Citations

This map shows the geographic impact of D Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Elder more than expected).

Fields of papers citing papers by D Elder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Elder. The network helps show where D Elder may publish in the future.

Co-authorship network of co-authors of D Elder

This figure shows the co-authorship network connecting the top 25 collaborators of D Elder. A scholar is included among the top collaborators of D Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Elder. D Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Wagner, Stephan N., Rajasekharan Somasundaram, Georgios Karanikas, et al.. (2010). CD20-immunotargeting of malignant melanoma.. Journal of Clinical Oncology. 28(15_suppl). 8565–8565. 3 indexed citations

Fecher, Leslie A., Keith T. Flaherty, Ravi K. Amaravadi, et al.. (2008). Phase I/II trial of imatinib and temozolomide in advanced unresectable melanoma. Journal of Clinical Oncology. 26(15_suppl). 9059–9059. 5 indexed citations

Kruper, Laura, Jeffrey Botbyl, D Elder, et al.. (2005). Predicting sentinel lymph node status in stage I/II melanoma. Journal of Clinical Oncology. 23(16_suppl). 7501–7501. 9 indexed citations

Montone, K., Patricia Van Belle, Rosalie Elenitsas, & D Elder. (1997). Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.. PubMed. 10(9). 939–44. 159 indexed citations

Elder, D, et al.. (1996). A unique case of long-term survival in a male patient with malignant melanoma of the distal urethra.. PubMed. 57(1). 44–6. 6 indexed citations

Seykora, John T. & D Elder. (1996). Dysplastic nevi and other risk markers for melanoma.. PubMed. 23(6). 682–7. 24 indexed citations

Hartge, Patricia, Elizabeth A. Holly, Allan C. Halpern, et al.. (1995). Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.. PubMed. 4(1). 37–40. 16 indexed citations

Guerry, DuPont, Michael Alexander, D Elder, & Meenhard Herlyn. (1987). Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.. The Journal of Immunology. 139(1). 305–312. 31 indexed citations

Elder, D, et al.. (1986). Assessment of survival rates with metastatic malignant melanomas.. PubMed. 162(3). 199–203. 6 indexed citations

10.

Ross, Alonzo H., Peter M. Grob, Mark Bothwell, et al.. (1984). Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.. Proceedings of the National Academy of Sciences. 81(21). 6681–6685. 281 indexed citations

11.

Thompson, John J., Meenhard Herlyn, D Elder, et al.. (1982). Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.. PubMed. 107(3). 357–61. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact